Skip to main content

Table 1 Patient characteristics of end-stage renal disease (ESRD) samples

From: V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

Sample

Conditiona

Genderb

Age (yr)

Comorbiditiesc

R1

Responder

M

65

DM + HTN + CAD

R2

Responder

F

43

CGN

R3

Responder

F

66

HTN + CGN

R4

Responder

M

62

DM + HTN

NR1

Non-responder (resistant)

M

63

DM + HTN

NR2

Non-responder (resistant)

F

46

CGN

NR3

Non-responder (resistant)

F

61

HTN + CGN

  1. aESRD patients’ erythropoietin (EPO) responsiveness. bM, male; F, female. cDiagnosed comorbidities: DM diabetes mellitus, HTN hypertension, CAD coronary artery disease, CGN chronic glomerulonephritis